An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Clinical trial NCT02577406 · COMPLETED
Trial details
- NCT number
- NCT02577406
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-30
- Primary completion
- 2020-03-17
- Enrollment
- 319
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.